E. Wallstrom et al., INCREASED REACTIVITY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDES AND EPITOPE MAPPING IN HLA DR2(15)-SCLEROSIS( MULTIPLE), European Journal of Immunology, 28(10), 1998, pp. 3329-3335
Multiple sclerosis (MS) is a central nervous system-specific inflammat
ory and demyelinating disease where a myelin-directed autoimmune respo
nse is thought to be pathogenetically relevant. Myelin oligodendrocyte
glycoprotein (MOG) is a surface-exposed minor myelin component that i
s a prime candidate autoantigen. We have investigated peripheral blood
lymphocyte responses to synthetic 15-26 amino acids long overlapping
MOG peptides in 20 MS patients and 14 healthy controls with the MS-ass
ociated HLA haplotype DR2(15). There were significantly increased resp
onses, in terms of numbers of cells secreting IFN-gamma detected by El
ispot in response to several MOG-derived peptides in the MS patients,
but not the healthy controls. MOG peptide 63-87 evoked the strongest r
esponse, and the stimulatory property of this peptide was confirmed in
additional DR2(15)+ MS patients where a peptide concentration-depende
nt proliferative response, which was inhibited by the addition of anti
-HLA class II antibodies, was observed. This is the first work detaili
ng putative immunodominant T cell epitopes of MOG in DR2(15)+ MS patie
nts.